This site uesd JavaScript.
Back Number
2011
2010
2009
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others
2006.12.22
DAIICHI SANKYO Announces Result of Early Retirement Program
2006.12.06
Fourth Sankyo Takamine Memorial Award Announced
2006.11.30
Restructuring of Group Companies
2006.11.30
Daiichi Pharmaceutical to Transfer All Daiichi Medical Shares
2006.11.30
DAIICHI SANKYO Announces Simplified Merger with Subsidiaries
2006.11.29
DAIICHI SANKYO, INC. ANNOUNCES FILING OF NEW DRUG APPLICATION FOR AMLODIPINE BESYLATE / OLMESARTAN MEDOXOMIL COMBINATION FOR THE TREATMENT OF HYPERTENSION
2006.11.06
Announcement of new corporate officers
2006.11.06
Announcement of Personnel Appointments of Affiliates
2006.10.27
Revisions of earnings forecasts for 1H FY 2006
2006.10.27
Business Transfer of the Chemical Products Business of Sankyo Lifetech (a subsidiary of Sankyo)
2006.10.26
Ultrasound Contrast Medium Sonazoid ® Gets Import Approval
2006.10.24
New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
2006.10.23
Canadian Levofloxacin Patent Upheld by Federal Judge
2006.10.19
Spin-off and Share Transfer of the Animal Health Products Business of Sankyo Lifetech (a subsidiary of Sankyo)
2006.10.10
Daiichi Pharmaceutical Korea to Become Wholly Owned Subsidiary of Daiichi Pharmaceutical Co., Ltd.
2006.10.02
DAIICHI SANKYO Subsidiary Files for Additional Pediatric Indication for Fentanyl Injection
2006.09.29
Transfer of Ameni-care Business of Sankyo Lifetech (a subsidiary of Sankyo) and Share Transfer of Sankyo Agro (a subsidiary of Sankyo)
2006.09.29
DAIICHI SANKYO Subsidiaries Announce Early Retirement Program
2006.09.29
Spin-off and Share Transfer of the Businesses in Food Additive and Drug Ingredients of Sankyo Lifetech (a subsidiary of Sankyo)
2006.09.22
About Today's News Reports Regarding Personnel Downsizing
2006.09.19
The Termination of the Contract concerning OTC Medicine
2006.09.11
DAIICHI SANKYO to Transfer All Daiichi Pure Chemicals Shares
2006.09.11
DAIICHI SANKYO to Transfer All Daiichi Radioisotope Laboratories Shares
2006.09.08
DAIICHI SANKYO to Invest in the Healthcare Venture Fund
2006.08.31
Sankyo and Ajinomoto Reach Agreement on the Development, Manufacture and Marketing of the New Diabetes Drug, AJD101
2006.08.03
Daiichi Wins FLOXIN® Otic Patent Challenge by Generic Manufacturer Apotex
2006.08.02
Sales of Antihypertensive Agent Olmetec® Begin in China
2006.08.02
SANKYO COMMENCES PATENT LITIGATION AGAINST BENICAR® ANDA FILING IN THE UNITED STATES
2006.08.01
Daiichi Pharmaceutical to Develop and Market Anti-EGFr Drug Nimotuzumab in Japan
2006.07.14
Sankyo's European Subsidiaries' Names Change
2006.07.14
Sales Agreement for EVISTA® Reached in Europe
2006.07.12
Launch of New Formulation Zyrtec® Dry Syrup 1.25% selective H1 receptor antagonist, anti-allergic agent
2006.06.16
Sankyo's Chinese Subsidiary Acquires Medicine Management Certificate
2006.05.26
DAIICHI SANKYO to Reduce Capital Reserves
2006.05.26
DAIICHI SANKYO to Amend the Articles of Incorporation
2006.05.22
Percutaneous Absorption-Type Analgesic and Anti-inflammatory Drug Loxonin Poultice 100mg to Go on Sale
2006.04.24
About the News Report on April 24
2006.04.24
Acceptance of Tender Offer for Wakodo
2006.04.17
Additional Payment Determined for the Transfer of All Zepharma Stocks
2006.04.04
Sales of Intrathecal Baclofen Therapy Products Begin
2006.03.31
Acquisition of Stocks in Zepharma Inc.
2006.03.31
About the News Report on March 31
2006.03.31
Announcement of Business Transfer to DAIICHI SANKYO HEALTHCARE
2006.03.30
Announcement of Revisions to Sankyo's Consolidated Financial Results for Prior Fiscal Years
2006.03.30
Announcement of Revisions to Consolidated Financial Results for the Interim Period of Fiscal 2005 (Six-Month Period Ended September 30, 2005)
2006.03.28
Announcement of the First DAIICHI SANKYO Group R&D Meeting
2006.03.23
American Subsidiaries of Daiichi Pharmaceutical and Sankyo to Integrate
2006.03.23
Sankyo and Exelixis Sign Joint Research Agreement
2006.02.17
Future Business Prospects of the Hyperlipidemia Drug Pravastatin in the United States
2006.01.31
Announcement of Revised Results Forecasts of the Sub-subsidiary Wakodo Co., Ltd.
2006.01.26
Sankyo Releases Lamisil AT® in New Female-Friendly Pink Packaging
2006.01.23
The Percutaneous Absorption-Type Analgesic and Anti-inflammatory Drug Loxonin Poultice 100mg Receives Approval for Manufacture
2006.01.10
KAI Pharmaceuticals, Inc. and Sankyo Company, Limited Enter Global Alliance to Develop and Commercialize Novel Compounds for Cardiovascular Disease
2006.01.06
Stock Transfer of F.P. Processing Co., Ltd., a Subsidiary of Sankyo
Back Number
2011
2010
2009
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others